Transforming growth factor beta (TGF beta) directs IgA1 and IgA2 switching in human naive B cells.
Schering-Plough, Laboratory for Immunological Research, Dardilly, France.
F
F
Briere
T
T
Defrance
B
B
Vanbervliet
J M
JM
Bridon
I
I
Durand
F
F
Rousset
J
J
Banchereau
D000911:Antibodies, Monoclonal / Q000276:immunology; D000941:Antigens / Q000276:immunology; D001402:B-Lymphocytes / Q000187:drug effects*; D019013:CD40 Antigens / Q000276:immunology; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D005347:Fibroblasts; D006801:Humans; D007070:Immunoglobulin A / Q000235:genetics*; D017578:Immunoglobulin Class Switching / Q000187:drug effects*; D016753:Interleukin-10 / Q000037:antagonists & inhibitors / Q000494:pharmacology; D017452:Receptors, IgG / Q000276:immunology; D011994:Recombinant Proteins / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
D000911:Antibodies, Monoclonal; D000941:Antigens; D019013:CD40 Antigens; D007070:Immunoglobulin A; D017452:Receptors, IgG; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; D016753:Interleukin-10